Hacker News
- BioNTech presents positive phase 1/2 data for CAR-T cell therapy candidate https://investors.biontech.de/news-releases/news-release-details/biontech-presents-positive-phase-12-data-update-car-t-cell/ 95 comments
- BioNTech-InstaDeep Early Warning System to Detect High-Risk SARS-CoV-2 Variants https://investors.biontech.de/news-releases/news-release-details/biontech-and-instadeep-developed-and-successfully-tested-early/ 64 comments
- BioNTech Plans to Address Infectious Diseases on the African Continent https://investors.biontech.de/news-releases/news-release-details/biontech-provides-update-plans-develop-sustainable-solutions 6 comments
- Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine 171 comments
- BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma | BioNTech https://investors.biontech.de/news-releases/news-release-details/biontech-announces-positive-topline-phase-2-results-mrna/ 4 comments technology
- BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer https://investors.biontech.de/news-releases/news-release-details/biontech-and-dualitybio-receive-fda-fast-track-designation/ 2 comments technology
- BioNTech shows strong 3 year follow up results on T cell Vaccine to increase remission and survival time in patients with pancreatic cancer https://investors.biontech.de/news-releases/news-release-details/three-year-phase-1-follow-data-mrna-based-individualized 14 comments wallstreetbets
- BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163 https://investors.biontech.de/news-releases/news-release-details/biontech-starts-phase-1-clinical-trial-prophylactic-herpes/ 7 comments health
- BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants https://investors.biontech.de/news-releases/news-release-details/biontech-and-instadeep-developed-and-successfully-tested-early/ 2 comments futurology